Share on:
Carlyle Group has hired investment bank Natixis to explore a sale of its stake in French medical equipment company Groupe Marle.
Marle specializes in orthopaedic implants, made from both alloys and polyethylene, and sells its products worldwide. The company is reported to produce one million implants annually and recorded €85MM (~US $97MM) in revenue for 2015.
Carlyle Group bought an 80% interest in Marle in 2009. The Marle family and management team retained a 20% stake.
Source: Wall Street Journal Â
In October 2015, Marle announced the acquisition of Finortho SAS, a company that specializes in polishing and sintering for rapid prototyping. Finortho was officially incorporated into Marle in January 2016 and became Marle Finishing SAS.
RELATED ARTICLES
Norwood Medical Appoints Gregg Olson as VP Sales & Marketing
Mar 27 2024 , Julie A. Vetalice
Tapping into the Promising Potential of AI in Orthopedics
Mar 26 2024 , BONEZONE Editors
4 Benefits of Additive Manufacturing Design in the Orthopedic Market
Mar 25 2024 , Paragon Medical
Materials Solutions for Medical Device Instrumentation
Mar 22 2024 , Carpenter Technology